The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus
Background.The role of adjuvant radiotherapy in the setting of uterine carcinosarcoma has not been clearly established. Methods.A retrospective review of 60 patients receiving definitive therapy for carcinosarcoma of the uterus was undertaken at a single institution. Twenty-nine of 60 patients were...
Gespeichert in:
Veröffentlicht in: | Gynecologic oncology 1998-01, Vol.68 (1), p.8-13 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 13 |
---|---|
container_issue | 1 |
container_start_page | 8 |
container_title | Gynecologic oncology |
container_volume | 68 |
creator | Gerszten, Kristina Faul, Clare Kounelis, Sophia Huang, Quingshou Kelley, Joseph Jones, Mirka W. |
description | Background.The role of adjuvant radiotherapy in the setting of uterine carcinosarcoma has not been clearly established.
Methods.A retrospective review of 60 patients receiving definitive therapy for carcinosarcoma of the uterus was undertaken at a single institution. Twenty-nine of 60 patients were treated with adjuvant radiotherapy.
Results.The addition of radiotherapy significantly reduced the local recurrence rate from 55% (17 patients) to 3% (1 patient). Adjuvant radiotherapy reduced the risk of distant failure and death in patients with disease confined to the uterus but did not impact distant recurrence or survival in stage III patients. Increasing stage and depth of myometrial tumor invasion were negatively associated with overall survival and disease-free survival but had no impact on local recurrence rates. The nuclear grade of the epithelial component was predictive of local recurrence (P= 0.0592), but epithelial architectural grade, grade of stromal component, and stromal versus epithelial predominance did not provide prognostic information. The relative risk of local recurrence of unirradiated patients versus irradiated patients was 17.54 (P= 0.0055) after adjusting for nuclear grade of the epithelial component.
Conclusions.Local failure represents a significant site of failure in the absence of adjuvant radiotherapy. The improvement in local failure rates with the addition of radiotherapy translates into an improvement in distant failure rates and survival only for patients with stage I/II disease. Epithelial nuclear grade, in addition to depth of myometrial invasion and stage, provides important prognostic information. Epithelial architectural grade, stromal grade, type of stromal component (homologous versus heterologous), and predominance of either stromal or epithelial component were not found to be significant prognostic factors. |
doi_str_mv | 10.1006/gyno.1997.4901 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79682320</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825897949015</els_id><sourcerecordid>79682320</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-801ed030771969786cb0025233f2df612ec1cbb9073157d09fe2a557395ade723</originalsourceid><addsrcrecordid>eNp1kEtLAzEUhYMotT627oRZiLupN5lJMlmW4qMgCKLrkCZ3NNKZ1GSm0H_vDC3duTqL893D5SPkhsKMAoiHr10bZlQpOSsV0BMypaB4LiquTskUQEFeMV6dk4uUfgCgAMomZKJKXgrOpmTx8Y3ZstkY22Whzubup9-atsvejfOh-8ZoNrsstNnCROvbkIYIjRnRocw-O4x9uiJntVknvD7kJfl8evxYvOSvb8_Lxfw1t2UhurwCim54QEqqhJKVsCsAxllR1MzVgjK01K5WCmRBuXSgamSGc1kobhxKVlyS-_3uJobfHlOnG58srtemxdAnLZWoWMFgAGd70MaQUsRab6JvTNxpCnq0pkdrerSmR2vDwe1huV816I74QdPQ3x16k6xZ19G01qcjxihnohyxao_hYGHrMepkPbYWnY9oO-2C_--DP-JahuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79682320</pqid></control><display><type>article</type><title>The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Gerszten, Kristina ; Faul, Clare ; Kounelis, Sophia ; Huang, Quingshou ; Kelley, Joseph ; Jones, Mirka W.</creator><creatorcontrib>Gerszten, Kristina ; Faul, Clare ; Kounelis, Sophia ; Huang, Quingshou ; Kelley, Joseph ; Jones, Mirka W.</creatorcontrib><description>Background.The role of adjuvant radiotherapy in the setting of uterine carcinosarcoma has not been clearly established.
Methods.A retrospective review of 60 patients receiving definitive therapy for carcinosarcoma of the uterus was undertaken at a single institution. Twenty-nine of 60 patients were treated with adjuvant radiotherapy.
Results.The addition of radiotherapy significantly reduced the local recurrence rate from 55% (17 patients) to 3% (1 patient). Adjuvant radiotherapy reduced the risk of distant failure and death in patients with disease confined to the uterus but did not impact distant recurrence or survival in stage III patients. Increasing stage and depth of myometrial tumor invasion were negatively associated with overall survival and disease-free survival but had no impact on local recurrence rates. The nuclear grade of the epithelial component was predictive of local recurrence (P= 0.0592), but epithelial architectural grade, grade of stromal component, and stromal versus epithelial predominance did not provide prognostic information. The relative risk of local recurrence of unirradiated patients versus irradiated patients was 17.54 (P= 0.0055) after adjusting for nuclear grade of the epithelial component.
Conclusions.Local failure represents a significant site of failure in the absence of adjuvant radiotherapy. The improvement in local failure rates with the addition of radiotherapy translates into an improvement in distant failure rates and survival only for patients with stage I/II disease. Epithelial nuclear grade, in addition to depth of myometrial invasion and stage, provides important prognostic information. Epithelial architectural grade, stromal grade, type of stromal component (homologous versus heterologous), and predominance of either stromal or epithelial component were not found to be significant prognostic factors.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1006/gyno.1997.4901</identifier><identifier>PMID: 9454652</identifier><identifier>CODEN: GYNOA3</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>adjuvant radiotherapy ; Aged ; Biological and medical sciences ; Carcinosarcoma - pathology ; Carcinosarcoma - radiotherapy ; Carcinosarcoma - surgery ; distant relapse ; Epithelium - pathology ; Female ; Genital system. Mammary gland ; Humans ; Hysterectomy - standards ; local relapse ; Lymph Node Excision ; Medical sciences ; Neoplasm Staging ; Prognosis ; prognostic factors ; Radiotherapy, Adjuvant - standards ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Retrospective Studies ; uterine carcinosarcoma ; Uterine Neoplasms - pathology ; Uterine Neoplasms - radiotherapy ; Uterine Neoplasms - surgery</subject><ispartof>Gynecologic oncology, 1998-01, Vol.68 (1), p.8-13</ispartof><rights>1998 Academic Press</rights><rights>1998 INIST-CNRS</rights><rights>Copyright 1998 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-801ed030771969786cb0025233f2df612ec1cbb9073157d09fe2a557395ade723</citedby><cites>FETCH-LOGICAL-c436t-801ed030771969786cb0025233f2df612ec1cbb9073157d09fe2a557395ade723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0090825897949015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,4036,4037,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2152642$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9454652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerszten, Kristina</creatorcontrib><creatorcontrib>Faul, Clare</creatorcontrib><creatorcontrib>Kounelis, Sophia</creatorcontrib><creatorcontrib>Huang, Quingshou</creatorcontrib><creatorcontrib>Kelley, Joseph</creatorcontrib><creatorcontrib>Jones, Mirka W.</creatorcontrib><title>The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Background.The role of adjuvant radiotherapy in the setting of uterine carcinosarcoma has not been clearly established.
Methods.A retrospective review of 60 patients receiving definitive therapy for carcinosarcoma of the uterus was undertaken at a single institution. Twenty-nine of 60 patients were treated with adjuvant radiotherapy.
Results.The addition of radiotherapy significantly reduced the local recurrence rate from 55% (17 patients) to 3% (1 patient). Adjuvant radiotherapy reduced the risk of distant failure and death in patients with disease confined to the uterus but did not impact distant recurrence or survival in stage III patients. Increasing stage and depth of myometrial tumor invasion were negatively associated with overall survival and disease-free survival but had no impact on local recurrence rates. The nuclear grade of the epithelial component was predictive of local recurrence (P= 0.0592), but epithelial architectural grade, grade of stromal component, and stromal versus epithelial predominance did not provide prognostic information. The relative risk of local recurrence of unirradiated patients versus irradiated patients was 17.54 (P= 0.0055) after adjusting for nuclear grade of the epithelial component.
Conclusions.Local failure represents a significant site of failure in the absence of adjuvant radiotherapy. The improvement in local failure rates with the addition of radiotherapy translates into an improvement in distant failure rates and survival only for patients with stage I/II disease. Epithelial nuclear grade, in addition to depth of myometrial invasion and stage, provides important prognostic information. Epithelial architectural grade, stromal grade, type of stromal component (homologous versus heterologous), and predominance of either stromal or epithelial component were not found to be significant prognostic factors.</description><subject>adjuvant radiotherapy</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carcinosarcoma - pathology</subject><subject>Carcinosarcoma - radiotherapy</subject><subject>Carcinosarcoma - surgery</subject><subject>distant relapse</subject><subject>Epithelium - pathology</subject><subject>Female</subject><subject>Genital system. Mammary gland</subject><subject>Humans</subject><subject>Hysterectomy - standards</subject><subject>local relapse</subject><subject>Lymph Node Excision</subject><subject>Medical sciences</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>prognostic factors</subject><subject>Radiotherapy, Adjuvant - standards</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Retrospective Studies</subject><subject>uterine carcinosarcoma</subject><subject>Uterine Neoplasms - pathology</subject><subject>Uterine Neoplasms - radiotherapy</subject><subject>Uterine Neoplasms - surgery</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtLAzEUhYMotT627oRZiLupN5lJMlmW4qMgCKLrkCZ3NNKZ1GSm0H_vDC3duTqL893D5SPkhsKMAoiHr10bZlQpOSsV0BMypaB4LiquTskUQEFeMV6dk4uUfgCgAMomZKJKXgrOpmTx8Y3ZstkY22Whzubup9-atsvejfOh-8ZoNrsstNnCROvbkIYIjRnRocw-O4x9uiJntVknvD7kJfl8evxYvOSvb8_Lxfw1t2UhurwCim54QEqqhJKVsCsAxllR1MzVgjK01K5WCmRBuXSgamSGc1kobhxKVlyS-_3uJobfHlOnG58srtemxdAnLZWoWMFgAGd70MaQUsRab6JvTNxpCnq0pkdrerSmR2vDwe1huV816I74QdPQ3x16k6xZ19G01qcjxihnohyxao_hYGHrMepkPbYWnY9oO-2C_--DP-JahuQ</recordid><startdate>199801</startdate><enddate>199801</enddate><creator>Gerszten, Kristina</creator><creator>Faul, Clare</creator><creator>Kounelis, Sophia</creator><creator>Huang, Quingshou</creator><creator>Kelley, Joseph</creator><creator>Jones, Mirka W.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199801</creationdate><title>The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus</title><author>Gerszten, Kristina ; Faul, Clare ; Kounelis, Sophia ; Huang, Quingshou ; Kelley, Joseph ; Jones, Mirka W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-801ed030771969786cb0025233f2df612ec1cbb9073157d09fe2a557395ade723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>adjuvant radiotherapy</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carcinosarcoma - pathology</topic><topic>Carcinosarcoma - radiotherapy</topic><topic>Carcinosarcoma - surgery</topic><topic>distant relapse</topic><topic>Epithelium - pathology</topic><topic>Female</topic><topic>Genital system. Mammary gland</topic><topic>Humans</topic><topic>Hysterectomy - standards</topic><topic>local relapse</topic><topic>Lymph Node Excision</topic><topic>Medical sciences</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>prognostic factors</topic><topic>Radiotherapy, Adjuvant - standards</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Retrospective Studies</topic><topic>uterine carcinosarcoma</topic><topic>Uterine Neoplasms - pathology</topic><topic>Uterine Neoplasms - radiotherapy</topic><topic>Uterine Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerszten, Kristina</creatorcontrib><creatorcontrib>Faul, Clare</creatorcontrib><creatorcontrib>Kounelis, Sophia</creatorcontrib><creatorcontrib>Huang, Quingshou</creatorcontrib><creatorcontrib>Kelley, Joseph</creatorcontrib><creatorcontrib>Jones, Mirka W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerszten, Kristina</au><au>Faul, Clare</au><au>Kounelis, Sophia</au><au>Huang, Quingshou</au><au>Kelley, Joseph</au><au>Jones, Mirka W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>1998-01</date><risdate>1998</risdate><volume>68</volume><issue>1</issue><spage>8</spage><epage>13</epage><pages>8-13</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><coden>GYNOA3</coden><abstract>Background.The role of adjuvant radiotherapy in the setting of uterine carcinosarcoma has not been clearly established.
Methods.A retrospective review of 60 patients receiving definitive therapy for carcinosarcoma of the uterus was undertaken at a single institution. Twenty-nine of 60 patients were treated with adjuvant radiotherapy.
Results.The addition of radiotherapy significantly reduced the local recurrence rate from 55% (17 patients) to 3% (1 patient). Adjuvant radiotherapy reduced the risk of distant failure and death in patients with disease confined to the uterus but did not impact distant recurrence or survival in stage III patients. Increasing stage and depth of myometrial tumor invasion were negatively associated with overall survival and disease-free survival but had no impact on local recurrence rates. The nuclear grade of the epithelial component was predictive of local recurrence (P= 0.0592), but epithelial architectural grade, grade of stromal component, and stromal versus epithelial predominance did not provide prognostic information. The relative risk of local recurrence of unirradiated patients versus irradiated patients was 17.54 (P= 0.0055) after adjusting for nuclear grade of the epithelial component.
Conclusions.Local failure represents a significant site of failure in the absence of adjuvant radiotherapy. The improvement in local failure rates with the addition of radiotherapy translates into an improvement in distant failure rates and survival only for patients with stage I/II disease. Epithelial nuclear grade, in addition to depth of myometrial invasion and stage, provides important prognostic information. Epithelial architectural grade, stromal grade, type of stromal component (homologous versus heterologous), and predominance of either stromal or epithelial component were not found to be significant prognostic factors.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>9454652</pmid><doi>10.1006/gyno.1997.4901</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-8258 |
ispartof | Gynecologic oncology, 1998-01, Vol.68 (1), p.8-13 |
issn | 0090-8258 1095-6859 |
language | eng |
recordid | cdi_proquest_miscellaneous_79682320 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | adjuvant radiotherapy Aged Biological and medical sciences Carcinosarcoma - pathology Carcinosarcoma - radiotherapy Carcinosarcoma - surgery distant relapse Epithelium - pathology Female Genital system. Mammary gland Humans Hysterectomy - standards local relapse Lymph Node Excision Medical sciences Neoplasm Staging Prognosis prognostic factors Radiotherapy, Adjuvant - standards Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Retrospective Studies uterine carcinosarcoma Uterine Neoplasms - pathology Uterine Neoplasms - radiotherapy Uterine Neoplasms - surgery |
title | The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the Uterus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A34%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Impact%20of%20Adjuvant%20Radiotherapy%20on%20Carcinosarcoma%20of%20the%20Uterus&rft.jtitle=Gynecologic%20oncology&rft.au=Gerszten,%20Kristina&rft.date=1998-01&rft.volume=68&rft.issue=1&rft.spage=8&rft.epage=13&rft.pages=8-13&rft.issn=0090-8258&rft.eissn=1095-6859&rft.coden=GYNOA3&rft_id=info:doi/10.1006/gyno.1997.4901&rft_dat=%3Cproquest_cross%3E79682320%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79682320&rft_id=info:pmid/9454652&rft_els_id=S0090825897949015&rfr_iscdi=true |